Your browser doesn't support javascript.
loading
Patient influenza vaccination reduces the risk of hospital-acquired influenza: An incident test negative-case control study in Lyon university hospital, France (2004-2020).
Saadatian-Elahi, Mitra; Henaff, Laetitia; Elias, Christelle; Nunes, Marta C; Hot, Arnaud; Martin-Gaujard, Géraldine; Escuret, Vanessa; Amour, Selilah; Vanhems, Philippe.
Afiliación
  • Saadatian-Elahi M; Service Hygiène, Epidémiologie et Prévention, Centre Hospitalier Hôpital Eduard Herriot, Hospices Civils de Lyon, 69437 Lyon Cedex, France; CIRI, Centre International de Recherche en Infectiologie, (Team Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID)), Univ Lyon
  • Henaff L; Service Hygiène, Epidémiologie et Prévention, Centre Hospitalier Hôpital Eduard Herriot, Hospices Civils de Lyon, 69437 Lyon Cedex, France; CIRI, Centre International de Recherche en Infectiologie, (Team Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID)), Univ Lyon
  • Elias C; Service Hygiène, Epidémiologie et Prévention, Centre Hospitalier Hôpital Eduard Herriot, Hospices Civils de Lyon, 69437 Lyon Cedex, France; CIRI, Centre International de Recherche en Infectiologie, (Team Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID)), Univ Lyon
  • Nunes MC; CIRI, Centre International de Recherche en Infectiologie, (Team Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID)), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France; Centre for Excellence in Respiratory Pa
  • Hot A; Internal Medicine, University Hospital Edouard Herriot, Hospices Civils de Lyon, France.
  • Martin-Gaujard G; Service de Gériatrie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
  • Escuret V; Laboratoire de Virologie, Institut des Agents Infectieux, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Virpath - Grippe, de l'émergence au contrôle, Centre International de Recherche en Infectiologie (CIRI), Inserm U111, CNRS 5308, ENS, UCBL1, Faculté de Médecine RTH Laënnec, L
  • Amour S; Service Hygiène, Epidémiologie et Prévention, Centre Hospitalier Hôpital Eduard Herriot, Hospices Civils de Lyon, 69437 Lyon Cedex, France; CIRI, Centre International de Recherche en Infectiologie, (Team Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID)), Univ Lyon
  • Vanhems P; Service Hygiène, Epidémiologie et Prévention, Centre Hospitalier Hôpital Eduard Herriot, Hospices Civils de Lyon, 69437 Lyon Cedex, France; CIRI, Centre International de Recherche en Infectiologie, (Team Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID)), Univ Lyon
Vaccine ; 41(30): 4341-4346, 2023 07 05.
Article en En | MEDLINE | ID: mdl-37321894
BACKGROUND: Literature is limited on the impact of patient vaccination on the risk of hospital-acquired influenza (HAI). This test negative case-control study nested in a surveillance program aimed at evaluating the effectiveness of influenza vaccination in reducing the risk of HAI in hospitalized patients during 15 influenza seasons (2004-05 to 2019-20). METHODS: HAI cases were those who developed influenza like illness (ILI) symptoms at least 72 h after hospitalization and had a positive reverse transcriptase-polymerase chain reaction (RT-PCR). Controls were those with ILI symptoms and a negative RT-PCR test. A nasal swab as well as socio-demographic, clinical data and information on influenza vaccination were collected. RESULTS: Of the 296 patients included, 67 were confirmed HAI cases. Influenza vaccine coverage was significantly higher among controls compared to HAI cases (p = 0.002). The risk of HAI was reduced by almost 60 % in vaccinated patients. CONCLUSIONS: A better control of HAI can be achieved by vaccinating hospitalized patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Vacunas contra la Influenza / Gripe Humana Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Vacunas contra la Influenza / Gripe Humana Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article
...